SCHEMBL1633849

SCHEMBL1633849

CC(C)(C)OC(=O)c1n[nH]cc1B(O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GABRA1 P14867 3/20 0.32
GABRG2 P18507 3/20 0.32
GABRB3 P28472 3/20 0.32
GABRA5 P31644 3/20 0.32
GABRA3 P34903 2/20 0.31
GABRA2 P47869 2/20 0.31
GABRA4 P48169 2/20 0.31
GABRA6 Q16445 2/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRB2 P47870 1/20 0.31
GABRE P78334 1/20 0.31
GABRG1 Q8N1C3 1/20 0.31
GABRG3 Q99928 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1571777 0.82 ALDH1A1 (0.34) ALDH1A1LMNA
SCHEMBL7421480 0.79 ALDH1A1 (0.41) ALDH1A1LMNACYP2C9CYP2C19NPSR1
SCHEMBL27667445 0.78 ALDH1A1 (0.39) ALDH1A1LMNACYP2C9CYP2C19NPSR1
SCHEMBL27869406 0.77 ALDH1A1 (0.40) ALDH1A1LMNACYP2C9CYP2C19NPSR1
SCHEMBL20567149 0.77 LMNA (0.40) ALDH1A1LMNACYP2C9CYP2C19NPSR1
SCHEMBL38655809 0.76 ALDH1A1 (0.43) ALDH1A1LMNACYP2C9CYP2C19NPSR1
SCHEMBL6837421 0.76 HTT (0.31)
SCHEMBL21121082 0.75 ALDH1A1 (0.39) ALDH1A1LMNACYP2C9CYP2C19NPSR1
SCHEMBL8816833 0.75 ALDH1A1 (0.39) ALDH1A1LMNACYP2C9CYP2C19NPSR1
SCHEMBL21996840 0.73 ALDH1A1 (0.38) ALDH1A1LMNANPSR1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2705029-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES Rhizen Pharmaceuticals S.A. (CH) 2014-03-12 EP disclosed
WO-2012151525-A9 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-12-13 WO disclosed
WO-2012151525-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-11-08 WO disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed